Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Tendyne Holdings, Inc. Securityholder's Representative Committee v. Abbott Vascular, Inc. et al.
Case Number:
1:18-cv-01070
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 20, 2020
Abbott Can't Nix Suit Over Losing Out On $50M Merger Bonus
A Delaware federal judge on Thursday rejected Abbott Laboratories' bid to dismiss a suit by former stockholders of Tendyne Holdings Inc. claiming that a merger contract breach cost them $50 million, ruling the amended complaint alleges enough facts to keep the suit alive that the original complaint lacked.
-
July 19, 2018
Tendyne Investors Sue Abbott Over $50M Merger Bonus Miss
Former stockholders of Minnesota-based Tendyne Holdings Inc. sued Abbott Vascular Inc. for breach of a $225 million merger contract Thursday, accusing the latter in a federal lawsuit in Delaware of bungling or scuttling a heart valve development goal worth up to $50 million to the former's investors.